Lars Daae Horvei

Lars Daae Horvei serves as an Associate Professor in the Department of Clinical Medicine at UiT The Arctic University of Norway, Tromsø, specializing in thrombosis and hemostasis research. His academic profile centers on clinical investigations of venous thromboembolism (VTE) and its multifactorial risk landscape.

Horvei's research program demonstrates deep engagement with obesity-thrombosis connections, inflammatory pathways, and genetic determinants of clotting disorders. He leverages longitudinal data from the Tromsø Study to examine how body weight fluctuations, adiposity metrics, and inflammatory biomarkers like C-reactive protein and neutrophil-to-lymphocyte ratios modulate VTE risk. His work frequently addresses gender disparities in thrombosis recurrence and explores clinical interventions including surgical approaches for pulmonary embolism.

Analysis of his 2014-2018 publications reveals consistent focus on population-based epidemiology of thrombotic disorders, with particular attention to modifiable risk factors. Key thematic threads include obesity subtypes as independent VTE predictors, inflammation as the hypothesized 'missing link' between adiposity and clotting, and nuanced examination of anthropometric measures beyond BMI. His research bridges basic mechanisms with clinical applications, including compression therapy efficacy for deep vein thrombosis complications.

While no formal awards are documented in available materials, Horvei maintains active collaboration with prominent researchers including Sigrid Kufaas Brækkan and John-Bjarne Hansen. His work appears in high-impact hematology journals such as Journal of Thrombosis and Haemostasis and Haematologica, reflecting significant contributions to understanding thrombosis pathophysiology in real-world populations.